We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+12.09%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$683M
AUM Growth
-$101M
Cap. Flow
-$82.5M
Cap. Flow %
-12.08%
Top 10 Hldgs %
52.33%
Holding
153
New
26
Increased
35
Reduced
53
Closed
35

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$20M
2
BIIB icon
Biogen
BIIB
+$11.2M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.32M
4
ORA icon
Ormat Technologies
ORA
+$5.09M
5
OPK icon
Opko Health
OPK
+$5.01M

Top Sells

Rank Stock Value
1
ESLT icon
Elbit Systems
ESLT
+$29.2M
2
SHPG
Shire pic
SHPG
+$27M
3
AGN
Allergan plc
AGN
+$23M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$12.7M
5
VTRS icon
Viatris
VTRS
+$9.62M

Sector Composition

Rank Sector Weight
1 Healthcare 60.65%
2 Utilities 5.79%
3 Technology 1.86%
4 Consumer Discretionary 1.38%
5 Communication Services 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGIO icon
51
Agios Pharmaceuticals
AGIO
$1.79B
$3.25M 0.48%
+50,000
New +$3.28M
EGLT
52
DELISTED
Egalet Corporation
EGLT
$3.22M 0.47%
292,500
-32,500
-10% -$322K
SGEN
53
DELISTED
Seagen Inc. Common Stock
SGEN
$3.14M 0.46%
70,000
+20,000
+40% +$832K
KITE
54
DELISTED
Kite Pharma, Inc.
KITE
$3.08M 0.45%
50,000
-6,970
-12% -$491K
MDLZ icon
55
Mondelez International
MDLZ
$79.5B
$3.08M 0.45%
68,625
+9,150
+15% +$409K
IMDZ
56
DELISTED
Immune Design Corp.
IMDZ
$3.07M 0.45%
153,000
-17,000
-10% -$293K
ARWR icon
57
Arrowhead Research
ARWR
$11.9B
$2.99M 0.44%
486,000
-54,000
-10% -$306K
MA icon
58
Mastercard
MA
$502B
$2.98M 0.44%
+30,605
New +$3M
XLRN
59
DELISTED
Acceleron Pharma
XLRN
$2.93M 0.43%
60,000
-40,000
-40% -$1.44M
GNCA
60
DELISTED
Genocea Biosciences, Inc.
GNCA
$2.85M 0.42%
67,561
+20,411
+43% +$973K
V icon
61
Visa
V
$684B
$2.84M 0.42%
+36,600
New +$2.84M
SBUX icon
62
Starbucks
SBUX
$120B
$2.81M 0.41%
46,828
-15,855
-25% -$966K
FOMX
63
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$2.77M 0.41%
342,000
-38,000
-10% -$284K
BITI
64
DELISTED
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
$2.74M 0.4%
193,646
-3,154
-2% -$44.1K
PTNR
65
DELISTED
Partner Communications
PTNR
$2.7M 0.4%
617,951
– –
HON icon
66
Honeywell
HON
$77B
$2.65M 0.39%
+28,485
New +$2.61M
TVTX icon
67
Travere Therapeutics
TVTX
$5.2B
$2.6M 0.38%
135,000
-15,000
-10% -$300K
ITCI
68
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.6M 0.38%
48,400
-57,000
-54% -$2.88M
QURE icon
69
uniQure
QURE
$3.03B
$2.54M 0.37%
153,500
+38,500
+33% +$713K
EXEL icon
70
Exelixis
EXEL
$13.3B
$2.54M 0.37%
450,000
-50,000
-10% -$280K
CLCD
71
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$2.39M 0.35%
285,525
-31,725
-10% -$167K
AAP icon
72
Advance Auto Parts
AAP
$3.35B
$2.34M 0.34%
+15,555
New +$2.7M
HALO icon
73
Halozyme
HALO
$9.79B
$2.34M 0.34%
135,000
-15,000
-10% -$239K
SMMT icon
74
Summit Therapeutics
SMMT
$10.4B
$2.32M 0.34%
202,220
-2,980
-1% -$31K
FWP
75
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$2.31M 0.34%
17,357
-1,929
-10% -$310K
1 2
3
4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q4 2015 Portfolio in Review

As of Q4 2015, Sphera Funds Management held 153 positions worth $683M, down 13% from $784M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Sphera Funds Management withdrew a net $82.5M in Q4 2015, closing 35 positions and reducing 53 holdings. Its most notable exit was Elbit Systems, an estimated $29.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 56% a quarter earlier, followed by Utilities and Technology.

Against the trend, Sphera Funds Management opened a new position in Alphabet (Google) Class C worth $5.76M.

  • Sphera Funds Management's largest Q4 2015 buy was Alphabet (Google) Class C: 148,180 shares worth $5.76M.
  • Sphera Funds Management added most to Pfizer in Q4 2015, an estimated $20M increase.
  • Sphera Funds Management's biggest Q4 2015 reduction was Shire pic, cutting an estimated $27M.
  • Sphera Funds Management fully exited Elbit Systems in Q4 2015, selling an estimated $29.2M.
  • Sphera Funds Management's ten largest holdings make up 52% of its $683M portfolio in Q4 2015.
  • Sphera Funds Management opened 26 new positions and closed 35 in Q4 2015.
  • Sphera Funds Management's portfolio value fell 13% quarter-over-quarter to $683M.

Based on Sphera Funds Management's 13F filing for Q4 2015, filed 11 Feb 2016.